| Company Name: |
TargetMol |
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
|
| | L-2-(2-amino-1,4,5,6-tetrahydro-4-pyridyl)-N-[[(1-carboxyphenethyl)amino]carbonyl]glycyl-N-(1-formylphenethyl)-L-valinamide, stereoisomer Basic information |
| Product Name: | L-2-(2-amino-1,4,5,6-tetrahydro-4-pyridyl)-N-[[(1-carboxyphenethyl)amino]carbonyl]glycyl-N-(1-formylphenethyl)-L-valinamide, stereoisomer | | Synonyms: | L-2-(2-amino-1,4,5,6-tetrahydro-4-pyridyl)-N-[[(1-carboxyphenethyl)amino]carbonyl]glycyl-N-(1-formylphenethyl)-L-valinamide, stereoisomer;2-[(2-Amino-1,4,5,6-tetrahydropyrimidin)-4-yl]-N-[[(1-carboxy-2-phenylethyl)amino]carbonyl]-L-Gly-N-(1-formyl-2-phenylethyl)-L-Val-NH2;Chymostatin B;Einecs 257-383-4;L-2-(2-Amino-1,4,5,6-tetrahydro-4-pyridyl)-N-(((1-carboxyphenethyl)amino)carbonyl)glycyl-N-(1-formylphenethyl)-L-valinamide, stereoisomer;L-Valinamide, (2S)-2-[(4S)-2-amino-3,4,5,6-tetrahydro-4-pyrimidinyl]-N-[[[(1S)-1-carboxy-2-phenylethyl]amino]carbonyl]glycyl-N-(1-formyl-2-phenylethyl)- | | CAS: | 51759-77-4 | | MF: | C30H39N7O6 | | MW: | 593.67 | | EINECS: | 257-383-4 | | Product Categories: | | | Mol File: | 51759-77-4.mol | ![L-2-(2-amino-1,4,5,6-tetrahydro-4-pyridyl)-N-[[(1-carboxyphenethyl)amino]carbonyl]glycyl-N-(1-formylphenethyl)-L-valinamide, stereoisomer Structure](CAS/20210305/GIF/51759-77-4.gif) |
| | L-2-(2-amino-1,4,5,6-tetrahydro-4-pyridyl)-N-[[(1-carboxyphenethyl)amino]carbonyl]glycyl-N-(1-formylphenethyl)-L-valinamide, stereoisomer Chemical Properties |
| density | 1.36±0.1 g/cm3(Predicted) | | pka | 3.75±0.10(Predicted) |
| | L-2-(2-amino-1,4,5,6-tetrahydro-4-pyridyl)-N-[[(1-carboxyphenethyl)amino]carbonyl]glycyl-N-(1-formylphenethyl)-L-valinamide, stereoisomer Usage And Synthesis |
| Uses | Chymostatin B is a subtype of chymostatin characterized by a valine residue. Chymostatin inhibits chymotrypsin, papain, and other serine/cysteine endopeptidases[1]. | | Definition | ChEBI: Einecs 257-383-4 is a dipeptide. | | References | [1] Delbaere LT, et al. Structure of the complex formed between the bacterial-produced inhibitor chymostatin and the serine enzyme Streptomyces griseus protease A. J Mol Biol. 1980 May 5;139(1):45-51. DOI:10.1016/0022-2836(80)90114-x |
| | L-2-(2-amino-1,4,5,6-tetrahydro-4-pyridyl)-N-[[(1-carboxyphenethyl)amino]carbonyl]glycyl-N-(1-formylphenethyl)-L-valinamide, stereoisomer Preparation Products And Raw materials |
|